RNA interference is provided for inhibition of ocular hypertension target mRNA expression for lowering elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Ocular hypertension targets include carbonic anhydrase II, IV, and XII; ß1- and ß2 adrenergic receptors; acetylcholinesterase; Na<SUP>+</SUP>/K<SUP>+</SUP>-ATPase; and Na-K-2Cl cotransporter. Ocular hypertension is treated by administering interfering RNAs of the present invention.
申请公布号
WO2006083945(A2)
申请公布日期
2006.08.10
申请号
WO2006US03515
申请日期
2006.02.01
申请人
ALCON, INC.;SHEPARD, ALLAN, R.;CHATTERTON, JON, E.;CLARK, ABBOT, F.;WAX, MARTIN, B.
发明人
SHEPARD, ALLAN, R.;CHATTERTON, JON, E.;CLARK, ABBOT, F.;WAX, MARTIN, B.